Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 10,4x - 11,5x | 11,0x |
| Selected Fwd EBIT Multiple | 8,1x - 9,0x | 8,6x |
| Fair Value | €0,30 - €0,43 | €0,37 |
| Upside | -37,7% - -11,4% | -24,5% |
| Benchmarks | Ticker | Full Ticker |
| Lenzing Aktiengesellschaft | LNZN.F | OTCPK:LNZN.F |
| Carbios SAS | ALCRB | ENXTPA:ALCRB |
| DuPont de Nemours, Inc. | DD * | BMV:DD* |
| Controladora Alpek, S. A. B. de C. V. | CTALPEK A | BMV:CTALPEKA |
| Cydsa, S.A.B. de C.V. | CYDSASA A | BMV:CYDSASAA |
| ALPEK, S.A.B. de C.V. | 27A | DB:27A |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| LNZN.F | ALCRB | DD * | CTALPEK A | CYDSASA A | 27A | ||
| OTCPK:LNZN.F | ENXTPA:ALCRB | BMV:DD* | BMV:CTALPEKA | BMV:CYDSASAA | DB:27A | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -20.4% | NM- | -1.7% | NM- | 5.9% | -5.5% | |
| 3Y CAGR | -36.0% | NM- | -0.5% | NM- | 12.3% | -29.6% | |
| Latest Twelve Months | 2462.3% | 1.5% | 18.8% | 43.1% | -9.4% | 16.3% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 2.3% | -27018.8% | 14.8% | 6.5% | 18.2% | 7.7% | |
| Prior Fiscal Year | -3.0% | -120362.5% | 14.1% | 3.3% | 22.7% | 3.3% | |
| Latest Fiscal Year | 1.9% | -27586.0% | 15.1% | 4.8% | 18.5% | 4.8% | |
| Latest Twelve Months | 5.2% | -6048.1% | 16.2% | 4.8% | 16.1% | 3.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.03x | 191.28x | 3.04x | 0.46x | 1.32x | 0.44x | |
| EV / LTM EBITDA | 6.3x | -5.4x | 11.8x | 6.1x | 5.3x | 6.8x | |
| EV / LTM EBIT | 19.9x | -3.2x | 18.8x | 9.6x | 8.2x | 12.3x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -3.2x | 9.6x | 19.9x | ||||
| Historical EV / LTM EBIT | 3.8x | 9.0x | 11.6x | ||||
| Selected EV / LTM EBIT | 10.4x | 11.0x | 11.5x | ||||
| (x) LTM EBIT | 5,055 | 5,055 | 5,055 | ||||
| (=) Implied Enterprise Value | 52,728 | 55,503 | 58,278 | ||||
| (-) Non-shareholder Claims * | (40,785) | (40,785) | (40,785) | ||||
| (=) Equity Value | 11,942 | 14,718 | 17,493 | ||||
| (/) Shares Outstanding | 2,100.6 | 2,100.6 | 2,100.6 | ||||
| Implied Value Range | 5.69 | 7.01 | 8.33 | ||||
| FX Rate: MXN/EUR | 21.3 | 21.3 | 21.3 | Market Price | |||
| Implied Value Range (Trading Cur) | 0.27 | 0.33 | 0.39 | 0.49 | |||
| Upside / (Downside) | -45.1% | -32.3% | -19.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | LNZN.F | ALCRB | DD * | CTALPEK A | CYDSASA A | 27A | |
| Enterprise Value | 2,788 | 111 | 37,863 | 16,342 | 21,354 | 62,534 | |
| (+) Cash & Short Term Investments | 762 | 72 | 1,837 | 0 | 2,220 | 8,199 | |
| (+) Investments & Other | 87 | 5 | 1,112 | 0 | 190 | 63 | |
| (-) Debt | (2,323) | (45) | (7,682) | 0 | (14,511) | (44,054) | |
| (-) Other Liabilities | (341) | 0 | (452) | 0 | (484) | (4,992) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 972 | 143 | 32,678 | 16,342 | 8,768 | 21,749 | |
| (/) Shares Outstanding | 38.6 | 16.9 | 418.7 | 5,558.5 | 531.4 | 2,100.6 | |
| Implied Stock Price | 25.16 | 8.50 | 78.04 | 2.94 | 16.50 | 10.35 | |
| FX Conversion Rate to Trading Currency | 0.86 | 1.00 | 0.05 | 1.00 | 1.00 | 21.30 | |
| Implied Stock Price (Trading Cur) | 29.25 | 8.50 | 1,430.00 | 2.94 | 16.50 | 0.49 | |
| Trading Currency | USD | EUR | MXN | MXN | MXN | EUR | |
| FX Rate to Reporting Currency | 0.86 | 1.00 | 0.05 | 1.00 | 1.00 | 21.30 | |